Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Department of Medicine, University of California San Diego, La Jolla, CA, United States.
Front Immunol. 2022 Jul 22;13:951361. doi: 10.3389/fimmu.2022.951361. eCollection 2022.
Tissue-resident memory CD4 T cells (Trm) are thought to be a major contributor to asthma relapse, but the role of circulatory T cells in asthma exacerbations or to maintaining the population of lung Trm cells is not fully understood. Here, we used a house dust mite allergen-based murine model of asthma relapse, and monitored the development of lung effector/Trm phenotype CD44CD62LCD69 CD4 T cells. To determine the contribution of circulatory cells, mice were treated with FTY720, to block lymphocyte egress from lymph nodes. Inhibiting the primary migration of circulatory cells to the lungs mitigated the accumulation and expansion of allergen-driven Trm phenotype cells, but subsequent allergen challenges still resulted in strong lung inflammation and Trm cell accumulation. This was blocked if FTY720 was also given at the time of allergen re-exposure, showing that new circulatory cells contributed to this lung memory/effector T cell pool at times well after the initial sensitization. However, once lung-localized Trm cells developed at high frequency, circulatory cells were not required to maintain this population following allergen re-encounter, even though circulatory cells still were major contributors to the overall asthmatic lung inflammatory response. Our results suggest that strategies that target the response of circulatory memory T cells and Trm cells together might be required to strongly inhibit T cell reactivity to airborne allergens and to limit exacerbations of asthma and their reoccurrence, but the contribution of circulatory T cells might vary in long-term asthmatics possessing a large stable Trm cell population in the lungs.
组织驻留记忆 CD4 T 细胞(Trm)被认为是哮喘复发的主要原因,但循环 T 细胞在哮喘加重或维持肺 Trm 细胞群体中的作用尚未完全阐明。在这里,我们使用基于屋尘螨变应原的哮喘复发小鼠模型,监测了肺效应/Trm 表型 CD44CD62LCD69 CD4 T 细胞的发展。为了确定循环细胞的贡献,用 FTY720 处理小鼠以阻止淋巴细胞从淋巴结中迁出。抑制循环细胞向肺部的初次迁移可减轻过敏原驱动的 Trm 表型细胞的积累和扩增,但随后的过敏原挑战仍导致强烈的肺部炎症和 Trm 细胞积累。如果在过敏原再次暴露时也给予 FTY720,则可阻断这种情况,表明新的循环细胞在最初致敏后很久的时间内都会为该肺部记忆/效应 T 细胞池做出贡献。然而,一旦肺驻留的 Trm 细胞以高频率发育,即使循环细胞仍然是总体哮喘肺部炎症反应的主要贡献者,在再次遇到过敏原时也不需要循环细胞来维持该群体。我们的结果表明,需要针对循环记忆 T 细胞和 Trm 细胞的反应的策略来强烈抑制 T 细胞对空气传播过敏原的反应,并限制哮喘的加重及其复发,但循环 T 细胞的贡献在长期患有哮喘的患者中可能会有所不同,这些患者的肺部存在大量稳定的 Trm 细胞群体。